Related Experiment Video
Updated: Jul 16, 2025

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
Recent developments in membrane targeting antifungal agents to mitigate antifungal resistance
Devashish Mehta1, Varsha Saini1, Avinash Bajaj1
1Laboratory of Nanotechnology and Chemical Biology, Regional Centre for Biotechnology Faridabad-121001 Haryana India bajaj@rcb.res.in.
Abstract:
Fungal infections cause severe and life-threatening complications especially in immunocompromised individuals. Antifungals targeting cellular machinery and cell membranes including azoles are used in clinical practice to manage topical to systemic fungal infections. However, continuous exposure to clinically used antifungal agents in managing the fungal infections results in the development of multi-drug resistance via adapting different kinds of intrinsic and extrinsic mechanisms. The unique chemical composition of fungal membranes presents attractive targets for antifungal drug discovery as it is difficult for fungal cells to modify the membrane targets for emergence of drug resistance. Here, we discussed available antifungal drugs with their detailed mechanism of action and described different antifungal resistance mechanisms. We further emphasized structure-activity relationship studies of membrane-targeting antifungal agents, and classified membrane-targeting antifungal agents on the basis of their core scaffold with detailed pharmacological properties. This review aims to pique the interest of potential researchers who could explore this interesting and intricate fungal realm.
Insights
Antifungal drugs targeting fungal membranes are crucial for treating infections, especially with rising drug resistance. Research into these membrane-targeting agents offers new strategies against resistant fungal strains.
Area of Science:
- Mycology
- Pharmacology
- Medicinal Chemistry
Background:
- Fungal infections pose severe risks, particularly to immunocompromised individuals.
- Current antifungals, including azoles targeting cell membranes, face challenges due to emerging multi-drug resistance.
- Fungal cell membranes offer a promising target for novel antifungal drug discovery due to inherent resistance mechanisms.
Purpose of the Study:
- To review existing antifungal drugs targeting fungal membranes.
- To elucidate mechanisms of antifungal drug resistance.
- To explore structure-activity relationships and pharmacological properties of membrane-targeting antifungals.
Main Methods:
- Literature review of antifungal agents and resistance mechanisms.
- Analysis of structure-activity relationships for membrane-targeting compounds.
- Classification of membrane-targeting antifungals based on core scaffolds.
Main Results:
- Detailed discussion of antifungal drug mechanisms of action.
- Description of intrinsic and extrinsic antifungal resistance mechanisms.
- Categorization of membrane-targeting antifungals with their pharmacological profiles.
Conclusions:
- Membrane-targeting antifungals represent a vital area for combating drug-resistant fungal infections.
- Understanding structure-activity relationships is key to developing next-generation antifungals.
- Further research into fungal membrane targets is encouraged to address clinical challenges.
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Targeted Cancer Therapies
There are several types of targeted therapies against...

